ICD (International Congress of Dengue)

ICD (International Congress of Dengue)
Name	International Congress of Dengue
Abbreviation	ICD
Status	active
Genre	scientific conference
Frequency	biennial
Venue	various
First	19XX
Organizer	International Dengue Society

ICD (International Congress of Dengue) is a recurring international scientific meeting that convenes clinicians, epidemiologists, virologists, entomologists, public health officials, and policymakers to discuss dengue fever and related arboviral diseases. The congress gathers delegates from institutions such as World Health Organization, Centers for Disease Control and Prevention, Pan American Health Organization, London School of Hygiene & Tropical Medicine, and Pasteur Institute to present research, shape policy, and coordinate responses to outbreaks.

History

The origins of the congress trace to early collaborations among researchers from Rockefeller Foundation, Institut Pasteur, Oswaldo Cruz Foundation, Johns Hopkins University, and Harvard University following major dengue epidemics in the 20th century. Early meetings featured participants associated with Walter Reed Army Institute of Research, US Naval Medical Research Unit, University of São Paulo, National Institutes of Health, and University of Oxford, reflecting transnational networks that included representatives from Ministry of Health (Brazil), Ministry of Health (Thailand), and Ministry of Health (Philippines). Over successive decades the congress expanded links with agencies like Gavi, the Vaccine Alliance, Bill & Melinda Gates Foundation, Wellcome Trust, European Centre for Disease Prevention and Control, and academic centers such as Imperial College London, University of California, San Francisco, and Monash University. Prominent figures affiliated with the congress have included scientists from Institut Pasteur de Dakar, Duke University, Yale University, University of Malaya, and Mahidol University, reflecting a shift toward interdisciplinary collaboration among Centers for Disease Control and Prevention (Thailand), Australian National University, and regional research institutes.

Organization and Governance

The congress is governed by a steering committee comprising representatives from World Health Organization, Pan American Health Organization, Southeast Asian Ministries of Health Organization, African Union, European Commission, and leading universities like Columbia University and University of Tokyo. An executive secretariat coordinates logistics with partners such as UNICEF, Médecins Sans Frontières, Red Cross and Red Crescent Movement, Global Outbreak Alert and Response Network, and national bodies including Ministry of Health (India) and Ministry of Health (Indonesia). Scientific advisory boards have included members from Harvard T.H. Chan School of Public Health, National University of Singapore, Chinese Center for Disease Control and Prevention, Korea Disease Control and Prevention Agency, and Institut Pasteur de France to oversee peer review and program selection. Funding and sponsorship arrangements have involved Gavi, the Vaccine Alliance, Bill & Melinda Gates Foundation, European Commission Horizon 2020, Wellcome Trust, and philanthropic donors tied to institutions like Rockefeller Foundation and Howard Hughes Medical Institute.

Conferences and Locations

Meetings have been hosted in cities with active dengue research centers such as Bangkok, Rio de Janeiro, Singapore, Manila, Jakarta, Lima, Hanoi, Kuala Lumpur, Ho Chi Minh City, New Delhi, Lagos, Nairobi, and Bangladesh (Dhaka). Regional satellite symposia occurred in collaboration with conferences like International Congress of Tropical Medicine and Malaria, American Society of Tropical Medicine and Hygiene Annual Meeting, European Congress of Clinical Microbiology & Infectious Diseases, and Asia Pacific Dengue Summit, often co-located with institutions including Mahidol University, Universidad de São Paulo, National University of Singapore, and University of the Philippines. Host city selections have involved municipal health departments and national ministries such as Ministry of Public Health (Thailand), Ministry of Health (Brazil), and Department of Health (Philippines).

Scientific Program and Topics

The program typically includes plenary sessions, symposia, workshops, and poster sessions addressing virology, vectors, clinical management, and vaccines with contributions from researchers at Centers for Disease Control and Prevention, National Institutes of Health, Institut Pasteur, University of Oxford, Imperial College London, University of São Paulo, Mahidol University, National University of Singapore, and Monash University. Key topics cover dengue virus serotypes, vector ecology involving Aedes aegypti studies from Australian National University and Universidad de Chile, vaccine development including trials by GlaxoSmithKline, Takeda Pharmaceutical Company, Butantan Institute, and Sanofi Pasteur, antiviral therapeutics, and diagnostics developed by teams at Johns Hopkins University, University of California, San Diego, and Karolinska Institutet. Sessions also examine integrated vector management strategies informed by research from London School of Hygiene & Tropical Medicine, Oswaldo Cruz Foundation, Institut Pasteur de Madagascar, and modeling studies from Santa Fe Institute, Los Alamos National Laboratory, and Imperial College London.

Research Impact and Collaborations

The congress has catalyzed collaborations among laboratories at Institut Pasteur, Oswaldo Cruz Foundation, National Institutes of Health, Rockefeller University, Duke University, Yale University, Harvard University, University of São Paulo, and Mahidol University, leading to multicenter trials, pooled data repositories, and policy briefs adopted by World Health Organization, Pan American Health Organization, and national health ministries. Outcomes include coordinated vaccine trial networks linking Butantan Institute, Sanofi Pasteur, Takeda, and academic partners, vector control initiatives aligned with Bill & Melinda Gates Foundation grants, and genomic surveillance consortia incorporating Wellcome Sanger Institute, Broad Institute, Chinese Center for Disease Control and Prevention, and Institut Pasteur de Dakar. Joint publications have appeared in journals affiliated with Nature Publishing Group, The Lancet, New England Journal of Medicine, and PLOS Neglected Tropical Diseases with authors from Johns Hopkins University, University of Oxford, Imperial College London, Mahidol University, and University of the Philippines.

Public Health Initiatives and Outcomes

Policy and program recommendations emerging from the congress have informed national strategies in countries such as Brazil, Thailand, Philippines, Indonesia, Vietnam, Mexico, Colombia, India, and Sri Lanka, and have influenced guidance from World Health Organization and Pan American Health Organization. Initiatives include enhanced surveillance systems implemented by Centers for Disease Control and Prevention collaborations, vaccine introduction pilots coordinated with Gavi, the Vaccine Alliance and National Immunization Programs in partnership with Butantan Institute and Sanofi Pasteur, community engagement projects run with UNICEF and Red Cross and Red Crescent Movement, and cluster-randomized vector control trials supported by Wellcome Trust and Bill & Melinda Gates Foundation. Reported outcomes include strengthened laboratory networks linking National Institute of Virology (India), Pasteur Institute networks, reduced case burdens in pilot districts, and accelerated translation of research into national policy by ministries including Ministry of Health (Brazil) and Department of Health (Philippines).

Category:Medical conferences Category:Dengue fever